LYKOS THERAPEUTICS

Lobbying client · California · filed 2025 to 2025

Healthcare/pharmaceuticals

$180,000 Reported spend

2 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (53389), not by name.

Firms hired 1

LYKOS THERAPEUTICS $180,000 2 filings

Bills named in these filings 3

HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025

1 filing
HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026

1 filing
S 2121
SUPPORT for Patients and Communities Reauthorization Act of 2025

1 filing

Reported by year 1 year

2025 $180,000 2 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 2 total

2T

LYKOS THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $90,000 expenses · posted Jul 21, 2025

View → Q1

LYKOS THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $90,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.